<p id="presentations">
<b>Conference Presentations</b></br></br>
The Florey Neuroscience Seminar Series (October 2025) – Final PhD Oration.</br>
<i>Focal Cortical Malformations in Epilepsy: Disease Modelling, Mechanisms, and Precision Medicine.</i></br>
<small>*An abridged, earlier version of this talk was presented at The Florey Epilepsy and Neurodevelopment Seminar Series.</small></br></br>
Federation of European Neuroscience Societies (FENS) Regional Meeting 2025, and the Norwegian Research School in Neuroscience (NRSN) Pre-Meeting (Oslo, Norway) – Oral and Poster Presentations. </br>
James Spyrou, Lauren E Bleakley, Hannah Vanyai, Snezana Maljevic, Paul J Lockhart, Katherine B Howell, Christopher A Reid.</br> 
<i>The HCN channel inhibitor Org 34167 reduces epileptiform activity in an in utero electroporation-based mouse model of TSC/FCD2B.</i></br> 
<small>*Awarded a travel stipend supported by FENS, NRSN and NORA for the abstract.</small></br></br>
Epilepsy Melbourne Meeting 2025 – Oral and Poster Presentation.</br>
James Spyrou, Lauren E Bleakley, Hannah Vanyai, Snezana Maljevic, Paul J Lockhart, Katherine B Howell, Christopher A Reid. </br>
<i>The HCN channel inhibitor Org 34167 reduces epileptiform activity in an in utero electroporation-based 
mouse model of TSC/FCD2B.</i></br></br> 
Epilepsy Melbourne Meeting 2024 – Oral and Poster Presentation. </br>
James Spyrou, Khaing Phyu Aung, Hannah Vanyai, Richard J Leventer, Snezana Maljevic, Paul J Lockhart, Katherine B Howell, Christopher A Reid. </br>
<i>Slc35a2 mosaic knockout impacts cortical development, dendritic arborisation, and neuronal firing. </i></br>
<small>*Awarded the best ‘data blitz’ talk prize by the convenors of the Meeting and visiting Professor Fernando Cendes.</small></br></br> 
Translational Neurogenetics Mini-Retreat 2024 – Oral Presentation. </br>
<i>MOGHE Model: Functional Confirmation that Low Frequency Variants are Significant.</i></br></br>
Epilepsy Research Retreat 2023 – Oral Presentation and Chapter. </br>
James Spyrou, Hannah Vanyai, Snezana Maljevic, Paul Lockhart, Katherine Howell, Christopher Reid. </br>
<i>Mechanistic insights gained from a novel mouse model of MOGHE.</i></br></br> 
International Congress of Genetics (ICG) 2023 – Poster Presentation. </br>
James Spyrou, Hannah Vanyai, Snezana Maljevic, Paul Lockhart, Katherine Howell, Christopher Reid. </br>
<i>Recapitulation of a heterotopic neuron phenotype in a novel mouse model of MOGHE using <i>in utero</i> electroporation and CRISPR/Cas9.</i></br>
<small>*Received a travel award for the abstract by the convenors of the Congress.</small></br></br> 
Epilepsy Melbourne Meeting 2023 – Oral and Poster Presentation. </br>
James Spyrou, Hannah Vanyai, Snezana Maljevic, Paul Lockhart, Katherine Howell, Christopher Reid.</br>
<i>Recapitulation of a heterotopic neuron phenotype in a novel mouse model of MOGHE using in utero electroporation and CRISPR/Cas9.</i></br></br> 
Translational Neurogenetics Mini-Retreat 2023 – Oral Presentation. </br>
<i>Recapitulation of a heterotopic neuron phenotype in a novel mouse model of MOGHE.</i></br></br> 
Australian Neuroscience Society (ANS) Annual Meeting 2022 – Poster Presentation. </br>
James Spyrou, Paulo Pinares-Garcia, Chaseley McKenzie, Ian Forster, Ming Shiuan Soh, Erlina Mohamed Syazwan, Mohammed Atif, Christopher Reid. </br>
<i>Antidepressant-like activity of a brain penetrant HCN channel blocker in mice.</i></br></br> 
Epilepsy Melbourne Meeting 2022 – Poster Presentation. </br>
James Spyrou, Paulo Pinares-Garcia, Chaseley McKenzie, Hannah Vanyai, Michael Hildebrand, Christopher Reid. </br>
<i>A Mouse Model of Tuberous Sclerosis Complex (TSC) and Focal Cortical Dysplasia Type 2B (FCD2B) using In Utero Electroporation.</i></br>
<small>*Awarded the best poster prize by representatives of the Australian Epilepsy Project.</small></br></br> 
International Society for Stem Cell Research (ISSCR) Annual Meeting 2018 – Poster Presentation.</br>
James Spyrou, David K Gardner, Alexandra J Harvey. </br>
<i>Transcriptomic and metabolic analyses reveal reprogramming conditions impact the human iPSC response to oxygen and identify retention of somatic cell metabolic memory.</i></br>
<small>*Received a travel award supported by the ASSCR and the NSCFA for the abstract.</small></br></br> 
Stem Cells Australia (SCA) Retreat 2017 – Poster Presentation. </br>
James Spyrou, David K Gardner, Alexandra J Harvey. </br>
<i>Long-term mitochondrial alterations in hiPSC can be induced by reprogramming at physiological oxygen.</i>
</p>
